These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12958347)

  • 1. Immunology. Hide and seek in the peptidome.
    Yewdell JW
    Science; 2003 Sep; 301(5638):1334-5. PubMed ID: 12958347
    [No Abstract]   [Full Text] [Related]  

  • 2. Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1.
    Yin Y; Manoury B; Fåhraeus R
    Science; 2003 Sep; 301(5638):1371-4. PubMed ID: 12958359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology. Nothing 'gainst time's scythe can make defense..
    Ploegh HL
    Science; 2004 May; 304(5675):1262-3. PubMed ID: 15166355
    [No Abstract]   [Full Text] [Related]  

  • 4. Epstein-Barr virus: exploiting the immune system by interfering with defective ribosomal products.
    Apcher S; Fahraeus R; Manoury B
    Microbes Infect; 2004 Nov; 6(13):1212-8. PubMed ID: 15488741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus.
    Lautscham G; Rickinson A; Blake N
    Microbes Infect; 2003 Apr; 5(4):291-9. PubMed ID: 12706442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avoiding proteasomal processing: the case of EBNA1.
    Dantuma NP; Sharipo A; Masucci MG
    Curr Top Microbiol Immunol; 2002; 269():23-36. PubMed ID: 12224511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology: professional secrets.
    Roy CR
    Nature; 2003 Sep; 425(6956):351-2. PubMed ID: 14508466
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.
    Levitskaya J; Sharipo A; Leonchiks A; Ciechanover A; Masucci MG
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12616-21. PubMed ID: 9356498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune surveillance obstructed by viral mRNA.
    Starck SR; Cardinaud S; Shastri N
    Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9135-6. PubMed ID: 18599434
    [No Abstract]   [Full Text] [Related]  

  • 10. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generating MHC class I ligands from viral gene products.
    Yewdell J; Antón LC; Bacik I; Schubert U; Snyder HL; Bennink JR
    Immunol Rev; 1999 Dec; 172():97-108. PubMed ID: 10631940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat sequence of Epstein-Barr virus-encoded nuclear antigen 1 protein interrupts proteasome substrate processing.
    Zhang M; Coffino P
    J Biol Chem; 2004 Mar; 279(10):8635-41. PubMed ID: 14688254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological functions of the proteasome.
    Niedermann G
    Curr Top Microbiol Immunol; 2002; 268():91-136. PubMed ID: 12083010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus and the immune system. Hide and seek.
    Cohen JI
    JAMA; 1997 Aug; 278(6):510-3. PubMed ID: 9256227
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advance in the study on the proteasome activator PA28].
    Murata S; Chiba T
    Tanpakushitsu Kakusan Koso; 2000 Aug; 45(11):1832-40. PubMed ID: 10936967
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitating protein synthesis, degradation, and endogenous antigen processing.
    Princiotta MF; Finzi D; Qian SB; Gibbs J; Schuchmann S; Buttgereit F; Bennink JR; Yewdell JW
    Immunity; 2003 Mar; 18(3):343-54. PubMed ID: 12648452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.
    Guermonprez P; Saveanu L; Kleijmeer M; Davoust J; Van Endert P; Amigorena S
    Nature; 2003 Sep; 425(6956):397-402. PubMed ID: 14508489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To DRiP or not to DRiP: generating peptide ligands for MHC class I molecules from biosynthesized proteins.
    Yewdell J
    Mol Immunol; 2002 Oct; 39(3-4):139-46. PubMed ID: 12200046
    [No Abstract]   [Full Text] [Related]  

  • 19. How do endogenous proteins become peptides and reach the endoplasmic reticulum.
    Nandi D; Marusina K; Monaco JJ
    Curr Top Microbiol Immunol; 1998; 232():15-47. PubMed ID: 9557392
    [No Abstract]   [Full Text] [Related]  

  • 20. Lessons from an age-old war.
    Powis SH
    Nat Med; 1998 Aug; 4(8):887-8. PubMed ID: 9701231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.